A growing number of infections—such as pneumonia, gonorrhea and tuberculosis—are becoming harder to treat, as bacteria evolve defenses against antibiotics faster than we can develop new drugs to replace them.
Cell & Microbiology
May 16, 2019
0
54
A recent study by a team of researchers at the University of Georgia provides insight into how and why bacteria become resistant to commonly used antibiotics over time.
Cell & Microbiology
Sep 19, 2018
0
60
Through computer simulations, scientists can predict if bacteria can be stopped with popular antibacterial therapies or not – a breakthrough which will help select and develop effective treatments for bacterial infections.
Biochemistry
Jun 8, 2018
0
71
Research from the University of Illinois at Chicago suggests bond duration, not bond tightness, may be the most important differentiator between antibiotics that kill bacteria and antibiotics that only stop bacterial growth.
Biochemistry
Dec 12, 2017
0
27
Antibiotic resistant bacterial pathogens are on the rise, while fewer antibiotics are being developed. Prof. Ariel Kushmaro and his local and international colleagues tackled the need by focusing on the long pepper. Known ...
Molecular & Computational biology
Jul 30, 2024
0
1
New research being presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark, (April 15-18) has identified several gold-based compounds with the potential to ...
Cell & Microbiology
Apr 7, 2023
1
29
Antibiotics have worked to save many people's lives from bacterial infection. But as more and more antibiotics are prescribed and used, bacteria are becoming resistant to antibiotic treatments, leaving the case open for researchers ...
Cell & Microbiology
Nov 7, 2016
1
9
Given the alarming rise of antibiotic-resistant bacteria, and the long lead-in time for developing novel drugs, the discovery of new ways to use the antibiotics already available and approved for use in humans is paramount. ...
Cell & Microbiology
Apr 8, 2015
0
26
A new antibiotic that is effective at killing anthrax and superbug MRSA bacteria could be a weapon in the fight against antibiotic resistance – and terrorism.
Biochemistry
Jul 31, 2013
1
0
